GGrantIndex
Sort

261,768 grants matching gene therapy

Integrated Systems Biology Approach to Diabetic Microvascular Complications

$1,045,153
Frank C Brosius · University Of Michigan At Ann Arbor · R24 · FY2011 · DK

Genome-Wide Discovery and Translational Research for Neural Repair

$1,044,975
Stephen M Strittmatter · Yale University · R35 · FY2019 · NS

NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND

$1,044,972
Harvard University (Sch Of Public Hlth) · R01 · FY2002 · HD

Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector

$1,044,958
David A Williams · Boston Children'S Hospital · U01 · FY2011 · AI

Pathophysiology of Human Blood Cells

$1,044,957
David A Williams · Boston Children'S Hospital · T32 · FY2025 · HL

Survey and SEER Data Collection Core

$1,044,936
Nancy K Janz · University Of Michigan At Ann Arbor · P01 · FY2014 · CA

Host Defense Regulation and Viral Oncogenesis

$1,044,934
Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2013 · CA

OSU as a Network Lead Academic Participating Site for the NCI NCTN

$1,044,921
Claire F Verschraegen · Ohio State University · UG1 · FY2025 · CA

Genome-Wide Discovery and Translational Research for Neural Repair

$1,044,907
Stephen M Strittmatter · Yale University · R35 · FY2020 · NS

Transgenic Models for Prostate and Breast Cancer

$1,044,851
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Genome-Wide Discovery and Translational Research for Neural Repair

$1,044,835
Stephen M Strittmatter · Yale University · R35 · FY2023 · NS

Genome-Wide Discovery and Translational Research for Neural Repair

$1,044,835
Stephen M Strittmatter · Yale University · R35 · FY2022 · NS

Genome-Wide Discovery and Translational Research for Neural Repair

$1,044,833
Stephen M Strittmatter · Yale University · R35 · FY2021 · NS

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,044,758
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Translating genomic discoveries to improved outcomes for high risk acute leukemia

$1,044,690
Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2019 · CA

Stem cells for therapeutics discovery in genetic blood disorders

$1,044,680
George Q Daley · Boston Children'S Hospital · U01 · FY2016 · HL

Targeting Lewy Body Specific Pathology Using Biomarkers

$1,044,669
Karen S Marder · Columbia University Health Sciences · U01 · FY2019 · NS

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

$1,044,600
Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2025 · CA

Xenobiotic-Metabolizing Enzymes

$1,044,513
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

GUANYLYL CYCLASE C AS A BI0MARKER FOR COLORECTAL CANCER

$1,044,444
Thomas Jefferson University · R01 · FY2004 · CA

Project 4: Precision Methods for Assessing Brain Health and Age-related Cognitive Impairment

$1,044,419
Nicholas Joseph Schork · University Of Arizona · U19 · FY2025 · AG

PET, APOE &The Preclinical Course of Alzheimer Disease

$1,044,341
Banner Good Samaritan Medical Center · R01 · FY2005 · MH

CYTOKINE GENE THERAPY OF CANCER

$1,044,326
University Of Pittsburgh At Pittsburgh · P01 · FY2000 · CA

Translational program for molecular therapeutics in DMD

$1,044,101
Hansell H Stedman · University Of Pennsylvania · U01 · FY2007 · NS

Studies in pig-to-primate cardiac xenotransplantation

$1,044,046
Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2012 · AI